M
Myron S. Cohen
Researcher at University of North Carolina at Chapel Hill
Publications - 576
Citations - 50913
Myron S. Cohen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 103, co-authored 549 publications receiving 46021 citations. Previous affiliations of Myron S. Cohen include University of Massachusetts Medical School & Scripps Health.
Papers
More filters
Journal ArticleDOI
Advances in HIV Prevention for Serodiscordant Couples
TL;DR: This review summarizes biobehavioral and biomedical HIV prevention options for serodiscordant couples focusing on advances in 2013 and 2014, including World Health Organization guidelines and best evidence for couples counseling, couple-based interventions, and the use of antiviral agents for prevention.
Journal ArticleDOI
Do humans neutrophils form hydroxyl radical? Evaluation of an unresolved controversy.
TL;DR: There is no definitive proof for hydroxyl radical formation by neutrophils, and in fact, neutrophil release of lactoferrin and myeloperoxidase appears to limit formation of this radical.
Journal ArticleDOI
COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact.
David A. Swan,Chloe Bracis,Holly Janes,Mia Moore,Laura Matrajt,Daniel B. Reeves,Eileen Burns,Deborah Donnell,Deborah Donnell,Myron S. Cohen,Joshua T. Schiffer,Joshua T. Schiffer,Dobromir T. Dimitrov,Dobromir T. Dimitrov +13 more
TL;DR: In this article, the authors assess and compare the population impact of vaccines with different efficacy profiles (VESYMP and VESUSC) satisfying licensure criteria, and develop a mathematical model of SARS-CoV-2 transmission.
Journal ArticleDOI
Characterization of HIV infection in cisgender men and transgender women who have sex with men receiving injectable cabotegravir for HIV prevention: HPTN 083
Mark A. Marzinke,Beatriz Grinsztejn,Jessica M. Fogel,Estelle Piwowar-Manning,Maoji Li,Lei Weng,Marybeth McCauley,Vanessa Cummings,Shahnaz Ahmed,Casey D Haines,Lane R. Bushman,Christos J. Petropoulos,Deborah Persaud,Adeola Adeyeye,Ryan Kofron,Alex R. Rinehart,Marty St. Clair,James F. Rooney,Daniel Pryluka,Lara E. Coelho,Aditya H. Gaur,Keren Middelkoop,Nittaya Phanuphak,Myron S. Cohen,Craig W. Hendrix,Peter L. Anderson,Brett Hanscom,Deborah Donnell,Raphael J. Landovitz,Susan H. Eshleman +29 more
TL;DR: Marzinke et al. as discussed by the authors showed that long-acting cabotegravir (CAB-LA) was more effective than tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for HIV prevention in cisgender men and transgender women who have sex with men.
Journal ArticleDOI
Control of sexually transmitted diseases in Haiti: results and implications of a baseline study among pregnant women living in Cite Soleil shantytowns.
Frieda Behets,Julio Desormeaux,Julio Desormeaux,Dania Joseph,Dania Joseph,Mario Adrien,Mario Adrien,Gessie Coicou,Gessie Coicou,Gina Dallabetta,Gina Dallabetta,Holli A. Hamilton,Holli A. Hamilton,Stoffel Moeng,Stoffel Moeng,Homer Davis,Homer Davis,Myron S. Cohen,Reginald Boulos,Reginald Boulos +19 more
TL;DR: Clinical assessment of cervical discharge, a World Health Organization algorithm, and a decision model based on local risk factors were 64%, 77%, and 89% sensitive, respectively, and 44%, 38%, and 43% specific, respectively for predicting cervical infection.